Home » Topics » BioWorld Science

BioWorld Science
RSS

AC-90222 exerts beneficial cognitive and antipsychotic effects in mice

Nov. 13, 2001

NPS receives milestone payment for potential schizophrenia treatment

Nov. 13, 2001

LJP-1082 enters phase I/II clinical trial for antibody-mediated thrombosis

Nov. 13, 2001

In vitro and in vivo studies show no lung deposition associated with Oralin

Nov. 13, 2001

FDA approves labeling change for Rhinocort Aqua

Nov. 13, 2001

New formulation of tamoxifen may treat resistant breast cancers

Nov. 13, 2001

Novel antidementia drug FK-960 more effective than and synergistic with donepezil

Nov. 13, 2001

WAY-812: a potent, long-acting 5-HT1A antagonist identified at Wyeth-Ayerst

Nov. 13, 2001

Phase I findings support advancement of CI-1023 to phase II evaluation

Nov. 13, 2001

Lipophilic metal chelator representative of new class of therapies for neurodegenerative disorders

Nov. 13, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...